Sanquin is responsible for safe and efficient blood supply in the Netherlands on a not-for-profit basis. Sanquin also develops and produces pharmaceutical products, conducts high-quality scientific research, and develops and performs a multitude of diagnostic services
Sanquin was established in 1998 through a merger between the Dutch blood banks and the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB). The Foundation is responsible for blood supply on a not-for-profit basis and advanced transfusion medicine as such that it fulfils the highest demands for quality, safety and efficiency. Sanquin delivers products and services, conducts scientific investigations and provides education, instruction, in-service training and refresher courses.
On the basis of the Blood Supply Act, Sanquin is the only organisation in the Netherlands authorised to manage our need for blood and blood products. It is also a not-for-profit organisation and thus has no profit motive. Sanquin employs approximately 3,000 workers all across the Netherlands.
The Sanquin organisation is constantly conducting research and developing new and improved blood products. There is also a constant search to replace the roughly 10% of the donors who become unavailable due to age, pregnancy, illness or relocation. At Sanquin, consistent quality and development through improvements therefore go hand in hand.
With Magister C24 we challenge the status quo. Magister C24 is the first fully automated blood group analyser specifically designed for laboratories with low throughput. We strongly believe this can help these labs forward as this allows them to work to the same high level of efficiency, quality and safety as labs with higher throughput. The design of Magister C24 ensures a cost-efficient, safe and fast work flow that is needed to continuously and quickly deliver accurate results to the clinic, which is necessary for optimal patient care.
For more information: www.magisterc24.com
Read more about Sanquin's work: